Reduced serological response to COVID-19 vaccines in patients with IBD is further diminished by TNF inhibitor therapy; Early results of the VARIATION study (VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON)
暂无分享,去创建一个
H. Mulcahy | G. Horgan | G. Doherty | M. Tosetto | J. Sheridan | J. Doherty | M. Buckley | G. Cullen | R. Stack | N. O' Morain | P. Doran | D. Daghfal | E. Mc Dermott | E. Ryan | P. Girod | Rosanna Inzitiari | C. O 'morain